Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) EBT (2024 - 2025)

RenovoRx (RNXT) has disclosed EBT for 2 consecutive years, with -$3.4 million as the latest value for Q4 2025.

  • Quarterly EBT fell 35.34% to -$3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.1 million through Dec 2025, down 14.14% year-over-year, with the annual reading at -$12.1 million for FY2025, 14.14% down from the prior year.
  • EBT hit -$3.4 million in Q4 2025 for RenovoRx, down from -$3.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$2.4 million in Q1 2024 to a low of -$3.4 million in Q4 2025.